Free movement of people is a fundamental right guaranteed by the Community law. Great strides have been made to encourage the 'free movement of students and workers' in order to 'ensure that health professionals go where they are most needed' [1] . However, our personal experience abroad tells that this is not always true.
We are two Italian medical oncologists from different institutes, recently landed in the Netherlands with the purpose of carrying out translational and clinical research. Being physicians and having a medical background, our ideal goal would be to combine research with clinical practice, to keep the contact with patients and make the experience complete.
We were deeply surprised to realize that we were not qualified to be registered and practice as specialists in the Netherlands and in several European countries alike.
Unlike other members of a multidisciplinary cancer team, medical oncology is not currently recognized as a professional qualification at European Union (EU) level [2] , and therefore, medical oncologists from a few European countries (e.g. Italy) are hindered in their professional mobility.
The standard requirements for training in medical oncology, according to the Global Core Curriculum, established by the European Society of Medical Oncology (ESMO) and American Society of Clinical Oncology [3] , comprise a total training period of 5-6 years (at least 2 years of internal medicine followed by 3-4 years of medical oncology).
Conversely, oncology residents are trained in a medical oncology department for 4 (currently 5) years to become medical oncologists in Italy [4] . Therefore, in our case, additional training would be required to be recognized as specialists. The duration and type of training are evaluated case by case from a committee of the specific host country, after detailed evaluation of the individual training program.
In this communication, we sought to share our experience with the community of European oncologists since the opportunity of continuing their career in a different European country might be prevented. Indeed, considered the shortage of medical oncologists in many European countries, cancer patients are prevented from having optimal access to specialized care. This is 'a matter of grave concern for the European Medical Oncology community' [5] and it would certainly benefit from the availability of international physicians.
Such issue has been already recognized many years ago [4] . Medical Oncology Status in Europe Survey (MOSES) provided detailed information on the different types of training in oncology and recognized the considerable lack of uniformity across the EU [6] . According to MOSES, several European countries (Czech Republic, Estonia, Finland, France, Italy, and Spain) lack an internal medicine training during the medical oncology specialization [6] .
The Green Paper on the European Workforce for Health (2008) clearly states the right of EU citizens to work in another Member State as an employee or civil servant in the context of the fundamental right of free movement [1, 7] . On April 2009, the European Union of Medical Specialists discussed about the mobility of health care workers and the need to assure that incoming staff hold proper qualifications to practice within Europe [8] .
The lack of complete validity of certain specialties in the EU might fuel the European physicians to prefer United States to Europe, where at the cost of additional training they can find a wider range of working opportunities.
ESMO agrees with the Green Paper that an effective and highly trained health care work force is required to face the various challenges to European health care systems.
Important and urgent measures have to be taken to guarantee European citizens to freely work across the EU. We believe that the medical oncology curriculum should meet the required length of training and include specified general internal medicine training, an essential feature of medical oncologists that distinguishes them from other specialists.
Therefore, the national competent authorities and specialist societies of European countries that still do not have such an adequate training should work together to accomplish this aim. For the sake of completeness, the Italian training in medical oncology has been extended up to 5 years in 2008. Noteworthy, it is not specified whether (and how long) the resident has to practice in a department of internal medicine.
Until then, we regret to note that for young Italian medical oncologists like us, barriers still exist across the EU. 
